Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

Oramed Pharmaceuticals  / Equity Bottom-Up

<ul><li>OraTech will leverage HTIT's manufacturing capabilities and focus on developing and commercializing innovative products globally based on ORMP's technology & pipeline.</li><li>HTIT is a high-tech company focused on biopharmaceutical product manufacturing and R&D with an emphasis on the oral delivery of therapeutic macromolecules.</li><li>It operates an oral insulin manufacturing facility in China.</li></ul>

OraTech will leverage HTIT's manufacturing capabilities and focus on developing and commercializing innovative products globally based on ORMP's technology & pipeline.HTIT is a high-tech company focused on biopharmaceutical product manufacturing and R&D with an emphasis on the oral delivery of therapeutic macromolecules.It operates an oral insulin manufacturing facility in China.

ORMP: Upcoming Expected Milestones Include OraTech Spin-Off & IPO, Launch of Phase 3 Trial